Renal Hypodysplasia/aplasia 1; Rhda1

Description

Renal hypodysplasia/aplasia belongs to a group of perinatally lethal renal diseases, including bilateral renal aplasia, unilateral renal agenesis with contralateral dysplasia (URA/RD), and severe obstructive uropathy. Renal aplasia falls at the most severe end of the spectrum of congenital anomalies of the kidney and urinary tract (CAKUT ), and usually results in death in utero or in the perinatal period. Families have been documented in which bilateral renal agenesis or aplasia coexists with unilateral renal aplasia, renal dysplasia, or renal aplasia with renal dysplasia, suggesting that these conditions may belong to a pathogenic continuum or phenotypic spectrum (summary by Joss et al., 2003; Humbert et al., 2014). Genetic Heterogeneity of Renal Hypodysplasia/AplasiaRHDA2 (OMIM ) is caused by mutation in the FGF20 gene (OMIM ) on chromosome 8p22, and RHDA3 (OMIM ) is caused by mutation in the GREB1L gene (OMIM ) on chromosome 18q11.

Clinical Features

Top most frequent phenotypes and symptoms related to Renal Hypodysplasia/aplasia 1; Rhda1

  • Pica
  • Hypertelorism
  • Cleft palate
  • Abnormal facial shape
  • Cryptorchidism
  • Low-set ears
  • Epicanthus
  • Pain
  • Hypertension
  • Talipes equinovarus
And another 37 symptoms. If you need more information about this disease we can help you.
Click here to know more about Mendelian.

Incidence and onset information

— Based on the latest data available Renal Hypodysplasia/aplasia 1; Rhda1 have a estimated birth prevalence of 1.7 per 100k worldwide.


Mendelian

Accelerate your rare disease diagnosis with us

Learn more

Renal Hypodysplasia/aplasia 1; Rhda1 Recommended genes panels

Panel Name, Specifity and genes Tested/covered
Renal aplasia 2 (sequence analysis of FGF20 gene).

By CGC Genetics in Portugal.

FGF20
Specificity
100 %
Genes
25 %
Congenital Abnormalities of the Kidney and Urinary Tract (CAKUT) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

DSTYK, CHD1L, HOXA4, HOXB6, CDC5L, GREB1L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, TBX18, FGF20, ITGA8, PBX1, ROBO2, AGT, SOX17, HPSE2, LIFR , (...)

View the complete list with 29 more genes
Specificity
9 %
Genes
100 %
Congenital Anomalies of Kidney and Urinary Tract (CAKUT) via FGF20 Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

FGF20
Specificity
100 %
Genes
25 %
Hereditary kidney disorders - different panels.

By Institute of Human Genetics Cologne University in Germany.

CLDN10, TMEM260, KANK3, SLC6A20, MAGEC1, TBC1D1, SLC41A1, SLC36A2, SLC22A10, KCNMB1, NRIP1, MAGED2, DYNC2LI1, IFT52, RMND1, MAPKBP1, MOCOS, SLC26A1, PDE3A, FN1 , (...)

View the complete list with 391 more genes
Specificity
1 %
Genes
75 %
Nephrology Endocrinology and Electrolytes - panels.

By MGZ Medical Genetics Center in Germany.

UPK2, DACH1, DSTYK, CHD1L, CDC5L, BMP7, SIX2, TRAP1, UPK3A, AGTR1, ANLN, FGF20, ITGA8, PTPRO, EMP2, CHRM3, BICC1, ROBO2, ARHGDIA, AGT , (...)

View the complete list with 97 more genes
Specificity
3 %
Genes
75 %
Renal hypodysplasia/aplasia.

By GeneTech ATS GeneTech Private Limited in India.

FGF20
Specificity
100 %
Genes
25 %
Renal Hypodysplasia /Aplasia.

By GeneTech ATS GeneTech Private Limited in India.

FGF20
Specificity
100 %
Genes
25 %
Renal Dysplasia, Renal Agenesia, CAKUT Panel.

By CeGaT GmbH in Germany.

ALDH1A2, OSR1, DSTYK, CHD1L, SPRY1, TRAP1, UPK3A, TBX18, FGF20, ITGA8, BICC1, ROBO2, SOX17, GDNF, FRAS1, FREM2, GRIP1, BMP4, FREM1, SDCCAG8 , (...)

View the complete list with 12 more genes
Specificity
10 %
Genes
75 %
FGF20.

By Fulgent Genetics Fulgent Genetics in United States.

FGF20
Specificity
100 %
Genes
25 %
KidneySeq - 264 Genes.

By Iowa Institute of Human Genetics University of Iowa in United States.

FN1, FAN1, DSTYK, CHD1L, SIX2, ARHGAP24, NUP107, NUP93, NUP205, FAT1, XPO5, SGPL1, TRAP1, UPK3A, AGTR1, TBX18, EHHADH, ANLN, FGF20, KCTD1 , (...)

View the complete list with 232 more genes
Specificity
2 %
Genes
75 %
Tempus xO assay.

By Tempus Labs, Inc. in United States.

SETD6, PIM3, MAP3K10, PDGFA, MAP3K11, PAK2, KHSRP, WASL, CASC11, GLIS1, NRG2, SOX21, SMARCC1, CUL4A, UTY, WNT9A, TEF, CHIC1, TRIM28, CDK11B , (...)

View the complete list with 1693 more genes
Specificity
1 %
Genes
50 %
Renal aplasia 1 (sequence analysis of ITGA8 gene).

By CGC Genetics in Portugal.

ITGA8
Specificity
100 %
Genes
25 %
Renal Hypodysplasia/Aplasia Type 3 via GREB1L Gene Sequencing with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

GREB1L
Specificity
100 %
Genes
25 %
GREB1L.

By Fulgent Genetics Fulgent Genetics in United States.

GREB1L
Specificity
100 %
Genes
25 %
MitoMet®Plus aCGH Analysis.

By Baylor Miraca Genetics Laboratories in United States.

GSN, NEFH, SOD1, TEAD1, PHB, PLA2G2A, AKAP10, PNKD, PAX2, CPOX, ABCB7, TAZ, TIMM8A, GK, PDHA1, HCCS, NYX, FRMD7, OTC, RP2 , (...)

View the complete list with 617 more genes
Specificity
1 %
Genes
25 %
Hereditary Paraganglioma/Pheochromocytoma Panel.

By Baylor Miraca Genetics Laboratories in United States.

MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
25 %
Hereditary Endocrine Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

CDC73, PRKAR1A, MAX, SDHD, TSHR, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Baylor Miraca Genetics Laboratories in United States.

RAD51D, PMS1, ENG, BARD1, RAD51C, CDC73, PRKAR1A, PRF1, CEBPA, SBDS, PAX5, GATA2, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET , (...)

View the complete list with 41 more genes
Specificity
2 %
Genes
25 %
MEN2 (RET) DNA Sequencing Test.

By Athena Diagnostics Inc in United States.

RET
Specificity
100 %
Genes
25 %
Pheochromocytoma Evaluation.

By Athena Diagnostics Inc in United States.

SDHB, RET, VHL
Specificity
34 %
Genes
25 %
Multiple endocrine neoplasia, type 2.

By Center for Human Genetics, Inc in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital in United States.

RET
Specificity
100 %
Genes
25 %
Hirschprungs Disease (RET mutations).

By Clinical Molecular Genetics Laboratory Johns Hopkins All Children's Hospital in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia.

By Molecular Pathology Laboratory Ohio State University in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By DNA Diagnostic Laboratory Henry Ford Hospital in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: MEN2A, Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: MEN2B Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: FMTC Sequencing.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

RET
Specificity
100 %
Genes
25 %
Inherited Cancer Panel.

By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University in United States.

CDKN1B, BAP1, XRCC2, MITF, NF1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, CDKN2A, CDK4 , (...)

View the complete list with 29 more genes
Specificity
3 %
Genes
25 %
VistaSeq Endrocrine Cancer Panel.

By Molecular Diagnostic Laboratory LabCorp in United States.

NF1, CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, TP53, PTEN, VHL
Specificity
8 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Genetics Laboratory University of Oklahoma Health Sciences Center in United States.

RET
Specificity
100 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DDX41, SAMD9L, SAMD9, POLE, ETV6, IKZF1, POLD1, SRP72, BAP1, TERT, TERC, NF1, RTEL1, CEBPA, PAX5, GATA2, BRIP1, SMAD4, BMPR1A, MAX , (...)

View the complete list with 34 more genes
Specificity
2 %
Genes
25 %
Hereditary Pheochromocytoma and Paraganglioma Panel.

By Genetic Services Laboratory University of Chicago in United States.

EGLN1, EPAS1, NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
8 %
Genes
25 %
Hyperparathyroidism Deletion/Duplication Panel.

By Genetic Services Laboratory University of Chicago in United States.

AP2S1, GNA11, CDKN1B, PTH1R, CASR, CDC73, MEN1, RET
Specificity
13 %
Genes
25 %
Hyperparathyroidism Sequencing Panel.

By Genetic Services Laboratory University of Chicago in United States.

AP2S1, GNA11, CDKN1B, PTH1R, CASR, CDC73, MEN1, RET
Specificity
13 %
Genes
25 %
Hereditary Thyroid Cancer Panel.

By Genetic Services Laboratory University of Chicago in United States.

DICER1, SRGAP1, WRN, AKT1, PIK3CA, PRKAR1A, CHEK2, SDHD, SDHB, RET, TP53, PTEN, APC
Specificity
8 %
Genes
25 %
Multiple Endorine Neoplasia Type 2.

By Molecular Genetics Laboratory - Diagnostics Genetics LabPLUS - Auckland City Hospital in New Zealand.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Service de Génétique Gustave Roussy in France.

RET
Specificity
100 %
Genes
25 %
Multiple Endoctine Neoplasia Type 2 (RET).

By Molecular Genetics Laboratory London Health Sciences Centre in Canada.

RET
Specificity
100 %
Genes
25 %
Central Hypoventilation Syndrome Panel (6 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
25 %
PulmoGene Panel (64 Genes).

By Laboratory for Molecular Medicine Laboratory for Molecular Medicine (Partners HealthCare Personalized Medicine) in United States.

GDNF, ASCL1, BDNF, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1 , (...)

View the complete list with 44 more genes
Specificity
2 %
Genes
25 %
Cancer Panel, Hereditary, Sequencing 46 Genes, Deletion/Duplication, 47 Genes.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

CDKN1B, BAP1, SMARCB1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1, SUFU, PALB2 , (...)

View the complete list with 27 more genes
Specificity
3 %
Genes
25 %
Multiple Endocrine Neoplasia (MEN2), RET Gene Mutations by Sequencing.

By ARUP Laboratories, Molecular Genetics and Genomics in United States.

RET
Specificity
100 %
Genes
25 %
RET Select Exons Sequencing (HSCR).

By GeneDx in United States.

RET
Specificity
100 %
Genes
25 %
RET Remaining Exons Sequencing (HSCR).

By GeneDx in United States.

RET
Specificity
100 %
Genes
25 %
RET Remaining Exons Sequencing (MEN2B).

By GeneDx in United States.

RET
Specificity
100 %
Genes
25 %
RET Select Exons Sequencing (MEN2B).

By GeneDx in United States.

RET
Specificity
100 %
Genes
25 %
PGL/PCC (Paraganglioma/Pheochromocytoma) Panel.

By GeneDx in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
25 %
Hereditary Cancer Panel - Endocrine/Paraganglioma-Pheochromocytoma17.

By Human Genetics Laboratory, Munroe-Meyer Institute University of Nebraska Medical Center in United States.

NF1, CDC73, PRKAR1A, MAX, SDHD, TSC1, TSC2, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
6 %
Genes
25 %
CancerNext-Expanded.

By Ambry Genetics in United States.

HOXB13, GALNT12, DICER1, POT1, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C, PRKAR1A, BRIP1 , (...)

View the complete list with 44 more genes
Specificity
2 %
Genes
25 %
CustomNext: Cancer.

By Ambry Genetics in United States.

NTHL1, HOXB13, GALNT12, DICER1, POT1, AIP, POLE, GREM1, POLD1, CDKN1B, BAP1, XRCC2, SMARCB1, SMARCA4, SMARCE1, MITF, NF1, RAD51D, BARD1, RAD51C , (...)

View the complete list with 48 more genes
Specificity
2 %
Genes
25 %
PGLNext.

By Ambry Genetics in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
25 %
RET gene sequence.

By Ambry Genetics in United States.

RET
Specificity
100 %
Genes
25 %
RET. Sequencing of the exons 5, 8, 13, 14 and 16.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Sequencing of the exons 10 and 11.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Sequencing of the exons 10 and 11.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Sequencing of the exons 13, 14, 15 and 16.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Complete sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
RET. Detection of the mutations p.Met918Thr and p.Ala883Phe by sequencing.

By Instituto de Medicina Genomica Instituto de Medicina Genomica in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia MEN2A - RET Proto-oncogene Full Sequence Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia MEN2A - RET Proto-oncogene Known Point Mutation Analysis.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

RET
Specificity
100 %
Genes
25 %
Hereditary Paraganglioma/Pheochromocytoma Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
25 %
Hereditary Endocrine Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

CDKN1B, CDC73, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
25 %
CHOP Comprehensive Hereditary Cancer Panel.

By Division of Genomic Diagnostics The Children's Hospital of Philadelphia in United States.

DDB2, DIS3L2, MTAP, CEBPE, POLH, ARID5B, HMBS, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, DDX41, COL7A1, G6PC3, ITK, ELANE, EXT1, EXT2 , (...)

View the complete list with 86 more genes
Specificity
1 %
Genes
25 %
RET-Related Hirschsprung Disease.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
RET-Related Renal Adysplasia.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
RET-Related Pheochromocytoma.

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Hirschsprung Disease (exons 2, 7, 15 and 19 of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Hirschsprung Disease (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Medullary thyroid carcinoma (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type 2A (frequent mutations of RET gene, exons 2, 10, 11 and 13 to 16).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type 2A (frequent mutations of RET gene, exons 5, 8, 10, 11, 13, 14, 15 and 16).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Familial medullary thyroid carcinoma (frequent mutations on RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Pheochromocytoma (frequent mutations on RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
OncoRisk (NGS panel for 48 genes).

By CGC Genetics in Portugal.

EXT1, EXT2, FANCA, FANCB, NF1, RAD51C, CDC73, PRKAR1A, CEBPA, BRIP1, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN1C, CDKN2A, CDK4 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
OncoRisk Plus (NGS panel for 89 genes).

By CGC Genetics in Portugal.

CEP57, DDB2, DIS3L2, XPC, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
2 %
Genes
25 %
Pheochromocytoma (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type 2A (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Pheochromocytoma and paraganglioma (NGS panel for 16 genes).

By CGC Genetics in Portugal.

GDNF, EGLN1, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
7 %
Genes
25 %
Hereditary amyloidosis (NGS panel of 19 genes).

By CGC Genetics in Portugal.

OSMR, IL31RA, LYZ, CST3, B2M, APOA2, TACSTD2, F10, TNFRSF1A, FGA, APOA1, PRNP, MEFV, NLRP3, GSN, RET, TGFBI, APP, TTR
Specificity
6 %
Genes
25 %
Multiple endocrine neoplasia type 2A (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Hereditary amyloidosis (NGS panel of 19 genes).

By CGC Genetics in Portugal.

OSMR, IL31RA, LYZ, CST3, B2M, APOA2, TACSTD2, F10, TNFRSF1A, FGA, APOA1, PRNP, MEFV, NLRP3, GSN, RET, TGFBI, APP, TTR
Specificity
6 %
Genes
25 %
Pheochromocytoma and paraganglioma (NGS panel for 16 genes).

By CGC Genetics in Portugal.

GDNF, EGLN1, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
7 %
Genes
25 %
Multiple Endocrine Neoplasia type 2B (sequence analysis of RET gene).

By CGC Genetics in Portugal.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia 2.

By Laboratory of Genetics HUSLAB in Finland.

RET
Specificity
100 %
Genes
25 %
RET-Related Pheochromocytoma.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
25 %
RET - Related Familial medullary thyroid carcinoma.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
25 %
RET-Related Hirschsprung Disease.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2B.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2A.

By Exeter Molecular Genetics Laboratory in United Kingdom.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Molecular Genetics, Function and Therapy Cyprus Institute of Neurology and Genetics in Cyprus.

RET
Specificity
100 %
Genes
25 %
Cancer Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, RET, TP53 , (...)

View the complete list with 11 more genes
Specificity
4 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2A (MEN2A) and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene - Tier 2.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2A (MEN2A) and Familial Medullary Thyroid Carcinoma (FMTC) via the RET Gene - Tier 1.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
25 %
Hirschsprung Disease (Non-syndromic) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NRTN, ECE1, GDNF, EDNRB, EDN3, RET
Specificity
17 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2B (MEN2B) via the RET Gene, Exons 15-16.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
25 %
Hereditary Paraganglioma-Pheochromocytoma Syndrome Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
9 %
Genes
25 %
Hirschsprung Disease (HSCR) via the RET Gene.

By PreventionGenetics PreventionGenetics in United States.

RET
Specificity
100 %
Genes
25 %
Congenital Central Hypoventilation Syndrome (CCHS) Sequencing Panel with CNV Detection.

By PreventionGenetics PreventionGenetics in United States.

BMP2, ASCL1, BDNF, EDN3, PHOX2B, PHOX2A, RET
Specificity
15 %
Genes
25 %
Endocrine tumours.

By Institute of Human Genetics Cologne University in Germany.

CDKN1B, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Custom solid tumor gene sequencing panel.

By Molecular Diagnostics Laboratory University Health Network in Canada.

RAC1, RICTOR, EIF1AX, HOXD8, ERBB4, CDKN2B, ERBB2, DDB2, CCND1, XPC, KDR, ERCC5, PDGFRB, CDK6, AKT1, GNA11, PDGFRA, SF3B1, EGFR, GNAQ , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By MGZ Medical Genetics Center in Germany.

RET
Specificity
100 %
Genes
25 %
Hereditary Cancer Syndromes - panels.

By MGZ Medical Genetics Center in Germany.

RNF43, CEP57, DDB2, DIS3L2, XPC, NTHL1, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, AXIN2, POLE, EGFR, GREM1 , (...)

View the complete list with 80 more genes
Specificity
1 %
Genes
25 %
Thyroid Cancer – Basic Diagnostics.

By MGZ Medical Genetics Center in Germany.

SDHD, SDHB, SDHC, RET, PTEN
Specificity
20 %
Genes
25 %
Pheochromozytoma-Paraganglioma syndrome.

By MGZ Medical Genetics Center in Germany.

NF1, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Thyroid Cancer.

By MGZ Medical Genetics Center in Germany.

DICER1, CHEK2, FLCN, SDHD, STK11, ATM, MEN1, SDHB, SDHC, RET, PTEN, MUTYH, APC
Specificity
8 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Bioscientia GmbH Center for Human Genetics in Germany.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia II.

By Synlab MVZ Humane Genetik München Synlab MVZ Humane Genetik München in Germany.

RET
Specificity
100 %
Genes
25 %
Sequencing of risk exons of the RET proto-oncogene (exons 10, 11, 13, 14, 15, 16).

By Department of Molecular Endocrinology Institute of Endocrinology in Czech Republic.

RET
Specificity
100 %
Genes
25 %
MEN2A.

By Genome Diagnostics Laboratory University Medical Center Utrecht in Netherlands.

RET
Specificity
100 %
Genes
25 %
Cancer Hotspot Panel.

By Centogene AG - the Rare Disease Company in Germany.

MYCL, ROS1, RPTOR, KIF5B, GNAI2, GNA13, EML4, BRD4, ARAF, NFE2L2, GNG2, KEAP1, NRG1, CCNE1, CD74, RICTOR, ERBB4, MYC, BCL6, SMO , (...)

View the complete list with 68 more genes
Specificity
2 %
Genes
25 %
Solid Tumor Panel.

By Centogene AG - the Rare Disease Company in Germany.

KMT2C, FGFR4, NTRK3, ROS1, AXL, SMO, ERBB2, DDR2, KDR, PDGFRB, PIK3R1, AKT1, GNA11, IDH1, PDGFRA, ABL1, JAK2, EGFR, GNAQ, PIK3CA , (...)

View the complete list with 42 more genes
Specificity
2 %
Genes
25 %
Central hypoventilation syndrome, congenital.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
Hirschsprung disease.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
Medullary thyroid carcinoma, somatic.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
RET, selective sequencing of exons 5, 8, 10, 11 and 13-16.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
AllNeuro panel.

By Centogene AG - the Rare Disease Company in Germany.

FCGR2B, TNF, ALOX5AP, PRKCH, TLR5, TIRAP, NOS2, XBP1, KCNK18, AANAT, SNIP1, EIF4E, ZBTB18, ADAM10, YAP1, ICAM1, SNX3, CISH, TAS2R38, FRG1 , (...)

View the complete list with 1185 more genes
Specificity
1 %
Genes
25 %
CentoICU platinum plus.

By Centogene AG - the Rare Disease Company in Germany.

OPLAH, PPM1K, IKBKB, LCK, CABS1, SOX6, OPRM1, IL2, CTPS1, IRF8, CD247, ADK, UQCC2, MPC1, UPB1, CORO1A, CD3G, MCM4, UQCRC2, GPHN , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
25 %
CentoICU platinum.

By Centogene AG - the Rare Disease Company in Germany.

FRAS1, TSPYL1, IL2RA, CARD11, NOTCH2, TNFRSF13C, PRKDC, ICOS, CD81, CR2, CD19, F7, JAGN1, ABCC2, NFKB2, IL12RB1, COL7A1, COL17A1, ITGA6, ITGB4 , (...)

View the complete list with 494 more genes
Specificity
1 %
Genes
25 %
Multiple endocrine neoplasia type IIA.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type IIB.

By Centogene AG - the Rare Disease Company in Germany.

RET
Specificity
100 %
Genes
25 %
Comprehensive pulmonary disease panel.

By Centogene AG - the Rare Disease Company in Germany.

GDNF, ASCL1, BDNF, NOP10, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4 , (...)

View the complete list with 46 more genes
Specificity
2 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By Medical Genetics Laboratory Diagenom GmbH in Germany.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia.

By bio.logis Center for Human Genetics Diagnosticum in Germany.

MEN1, RET
Specificity
50 %
Genes
25 %
Familial Tumor Syndromes Panel.

By CeGaT GmbH in Germany.

RASAL1, CYLD, DICER1, WRN, AKT1, PIK3CA, BAP1, SMARCB1, SMARCA4, SMARCE1, ATR, SPRED1, LZTR1, NF1, CDC73, MET, SDHD, CDKN2A, NF2, NBN , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
25 %
Pheochromocytoma and Paraganglioma Panel.

By CeGaT GmbH in Germany.

CDKN1B, NF1, PRKAR1A, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
8 %
Genes
25 %
Multiple Endocrine Neoplasia.

By Laboratory of Human Genetics GENOMED Health Care Center in Poland.

MEN1, RET
Specificity
50 %
Genes
25 %
RET.

By Innovagenomics Innovagenomics S.L in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2.

By DNAbiolab Cretan Center for Research and Development of Applications on Genetics and Molecular Biology in Greece.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type II, RET.

By GGA - Galil Genetic Analysis in Israel.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia type 2.

By Molecular Genetics and Cytogenetics, Clinical Laboratory Service Faculty of Medicine, Pontificia Universidad Católica de Chile in Chile.

RET
Specificity
100 %
Genes
25 %
Cancer Predisposition.

By Asper Biogene Asper Biogene LLC in Estonia.

DDB2, DIS3L2, XPC, RHBDF2, CYLD, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL, FANCM, SLX4 , (...)

View the complete list with 69 more genes
Specificity
2 %
Genes
25 %
Thyroid Cancer.

By Asper Biogene Asper Biogene LLC in Estonia.

DICER1, CDC73, PRKAR1A, SDHD, MEN1, SDHB, RET, TP53, PTEN, APC
Specificity
10 %
Genes
25 %
Multiple endocrine neoplasia type 2, RET sequencing.

By Molecular Diagnostics Laboratory Seoul National University Hospital in South Korea.

RET
Specificity
100 %
Genes
25 %
Hermansky-Pudlak Syndrome/Oculocutaneous Albinism/Pigmentation panel.

By Molecular Vision Laboratory in United States.

SLC38A8, MLPH, RAB27A, MYO5A, KIT, LYST, BLOC1S6, LRMDA, SLC24A5, MITF, SOX10, SNAI2, EDNRB, PAX3, EDN3, AP3B1, HPS3, HPS4, HPS5, HPS6 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
Hirschsprung Disease Panel.

By Molecular Vision Laboratory in United States.

EDNRB, EDN3, RET
Specificity
34 %
Genes
25 %
Waardenburg Syndrome panel.

By Molecular Vision Laboratory in United States.

MITF, SOX10, SNAI2, EDNRB, PAX3, EDN3, RET
Specificity
15 %
Genes
25 %
Central hypoventilation syndrome, congenital.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
Medullary thyroid carcinoma.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia 2A.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia 2B.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
Pheochromocytoma.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
Renal agenesis.

By Praxis fuer Humangenetik Wien in Austria.

RET
Specificity
100 %
Genes
25 %
CARCINOMA MEDULAR DE TIROIDES.

By GENETIX Centro de Investigación en Genética Humana y Reproductiva in Colombia.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia (MEN) 2B (screening RET proto-oncogene).

By Molecular Diagnosis Centre National University Hospital in Singapore.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia (MEN) 2A/FMTC (screening RET proto-oncogene).

By Molecular Diagnosis Centre National University Hospital in Singapore.

RET
Specificity
100 %
Genes
25 %
Inherited Cancer Screen.

By Counsyl in United States.

POLE, GREM1, POLD1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, MRE11, ATM, SDHA , (...)

View the complete list with 16 more genes
Specificity
3 %
Genes
25 %
qCancer Risk Expanded.

By Quantitative Genomic Medicine Laboratories, SL in Spain.

POLE, POLD1, MITF, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, MET, FLCN, SDHD, CDKN2A, CDK4, STK11, CDH1 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
Central hypoventilation syndrome, congenital.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Medullary thyroid carcinoma.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia 2A.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia 2B.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Pheochromocytoma.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Renal agenesis.

By MedGene in Slovakia.

RET
Specificity
100 %
Genes
25 %
Invitae Multiple Endocrine Neoplasia Type 2 Test.

By Invitae in United States.

RET
Specificity
100 %
Genes
25 %
Invitae Multi-Cancer Panel.

By Invitae in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, KIT, SMARCB1, SMARCA4, SMARCE1, TERT, TERC, MITF , (...)

View the complete list with 60 more genes
Specificity
2 %
Genes
25 %
Invitae Hyperparathyroidism Panel.

By Invitae in United States.

CDKN1B, CASR, CDC73, MEN1, RET
Specificity
20 %
Genes
25 %
Invitae Thyroid Cancer Panel.

By Invitae in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
25 %
Invitae Hereditary Paraganglioma-Pheochromocytoma Panel.

By Invitae in United States.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Invitae Pediatric Solid Tumors Panel.

By Invitae in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, SMARCE1, NF1, CDC73, PRKAR1A, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C, STK11, SUFU, NF2 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
Hirschsprung disease: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Renal Agenesis: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (exons 10, 11, 13-16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (exons 13-16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2A (MEN2A): RET gene sequence (exons 10, 11, 13, 14).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2A (MEN2A): RET gene sequence analysis (exons 10, 11).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2B (MEN2B): RET gene sequence analysis (exons 15, 16).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine Neoplasia type 2 (MEN2): RET gene sequence analysis (remaining exons: 1-9, 12, 17-20).

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: RET gene sequence analysis.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

RET
Specificity
100 %
Genes
25 %
ONCOLOGY, PANEL.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

POLH, XPC, HOXB13, XPA, ERCC5, AIP, ELANE, PDGFRA, GREM1, ERCC4, CDKN1B, XRCC2, FANCD2, FANCI, FANCL, SLX4, FANCE, FANCF, FANCG, FANCA , (...)

View the complete list with 60 more genes
Specificity
2 %
Genes
25 %
PARAGANGLIOMA-PHEOCHROMOCYTOMA.

By GENETAQ Molecular Genetics Centre and Diagnosis of Rare Diseases in Spain.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: RET Full Gene Sequencing.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: RET Gene Deletion/Duplication.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

RET
Specificity
100 %
Genes
25 %
Early Onset Inflammatory Bowel Disease: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

IL2RA, ICOS, TTC37, IL10RA, LRBA, STXBP2, XIAP, CD40LG, AICDA, NCF4, NCF2, SH2D1A, MEFV, FOXP3, MVK, BTK, WAS, DCLRE1C, CYBB, CYBA , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Congenital Central Hypoventilation Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, HOXA1, EDN3, PHOX2B, RET
Specificity
15 %
Genes
25 %
Pulmonary Disease: Comprehensive Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1, MUC5B, CCDC40, DNAL1 , (...)

View the complete list with 33 more genes
Specificity
2 %
Genes
25 %
Hereditary Cancer Syndrome: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
2 %
Genes
25 %
Endocrine Cancer: Sequencing Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MXD1, AIP, CDKN1B, CDC73, PRKAR1A, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
25 %
Pheochromocytoma-Paraganglioma: Sequencing and Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

MAX, SDHD, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
13 %
Genes
25 %
Congenital Central Hypoventilation Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

GDNF, ASCL1, BDNF, HOXA1, EDN3, PHOX2B, RET
Specificity
15 %
Genes
25 %
Early Onset Inflammatory Bowel Disease: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

IL2RA, ICOS, TTC37, IL10RA, LRBA, STXBP2, XIAP, CD40LG, AICDA, NCF4, NCF2, SH2D1A, MEFV, FOXP3, MVK, BTK, WAS, DCLRE1C, CYBB, CYBA , (...)

View the complete list with 6 more genes
Specificity
4 %
Genes
25 %
Endocrine Cancer: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
8 %
Genes
25 %
Hereditary Cancer Syndrome: Deletion/Duplication Panel.

By EGL Genetic Diagnostics Eurofins Clinical Diagnostics in United States.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
2 %
Genes
25 %
Hereditary Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC, AIP , (...)

View the complete list with 92 more genes
Specificity
1 %
Genes
25 %
Lung Disorders NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

GDNF, ASCL1, BDNF, SFTPA1, SFTPA2, DNAI1, SFTPB, BMPR2, DNAH5, NME8, SFTPC, ABCA3, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4, DNAAF1, MUC5B , (...)

View the complete list with 31 more genes
Specificity
2 %
Genes
25 %
Paraganglioma-Pheochromocytomas NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

EGLN1, NF1, MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, KIF1B, RET, SDHAF2, VHL
Specificity
9 %
Genes
25 %
Central Hypoventilation Syndrome NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
25 %
Thyroid Cancer NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

SDHD, NRAS, KRAS, HRAS, BRAF, SDHB, RET, TP53, PTEN, MUTYH
Specificity
10 %
Genes
25 %
Multiple Endocrine Neoplasia Type 1 NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

MEN1, RET
Specificity
50 %
Genes
25 %
Hirschsprung Disease NGS Panel.

By Fulgent Genetics Fulgent Genetics in United States.

ECE1, GDNF, EDNRB, EDN3, RET
Specificity
20 %
Genes
25 %
RET.

By Fulgent Genetics Fulgent Genetics in United States.

RET
Specificity
100 %
Genes
25 %
Focus Cancer Panel - 40 Genes.

By Fulgent Genetics Fulgent Genetics in United States.

RAD51, AXIN2, POLE, BAP1, KIT, NF1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2 , (...)

View the complete list with 20 more genes
Specificity
3 %
Genes
25 %
Thyroid Cancer Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
25 %
Comprehensive Cancer Panel.

By Fulgent Genetics Fulgent Genetics in United States.

RBM15, EXO1, XRCC3, PICALM, ROBO2, MSH3, DDB2, DIS3L2, XPC, HOXB13, CYLD, GALNT12, BUB1B, RAD51, XPA, ERCC5, DICER1, EGLN1, WRN, PRKDC , (...)

View the complete list with 104 more genes
Specificity
1 %
Genes
25 %
Paraganglioma-Pheochromocytoma Comprehensive Panel.

By Fulgent Genetics Fulgent Genetics in United States.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
RET Sequencing and Deletion/Duplication.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

RET
Specificity
100 %
Genes
25 %
MyVantage(TM) Hereditary Comprehensive Cancer Panel.

By Quest Diagnostics Nichols Institute San Juan Capistrano in United States.

POLE, POLD1, NF1, RAD51D, BARD1, RAD51C, BRIP1, SMAD4, BMPR1A, CHEK2, SDHD, CDKN2A, CDK4, STK11, CDH1, PALB2, NBN, ATM, MEN1, SDHB , (...)

View the complete list with 14 more genes
Specificity
3 %
Genes
25 %
Hyperparathyroidism Panel.

By Blueprint Genetics in Finland.

CDKN1A, CDKN2C, CDKN2B, GCM2, PTH, AP2S1, GNA11, CDKN1B, CASR, CDC73, AIRE, MEN1, RET
Specificity
8 %
Genes
25 %
Hirschsprung Disease Panel.

By Blueprint Genetics in Finland.

CELSR3, NRG1, NRTN, BDNF, MITF, SOX10, EDNRB, PAX3, EDN3, ZEB2, KIF1BP, L1CAM, PHOX2B, RMRP, RET
Specificity
7 %
Genes
25 %
Renal Malformation Panel.

By Blueprint Genetics in Finland.

DSTYK, PBX1, ROBO2, AGT, REN, CCNQ, FREM2, BMP4, FREM1, ACE, ACTG2, FANCB, FOXC2, GATA3, SIX1, SIX5, SALL1, PAX2, RET, HNF1B , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Hereditary Pediatric Cancer Panel.

By Blueprint Genetics in Finland.

REST, DIS3L2, BUB1B, DICER1, WRN, AXIN2, BAP1, SMARCB1, SMARCA4, EZH2, RRAS, RASA2, NSUN2, LZTR1, NF1, CDC73, PRKAR1A, PRF1, CEBPA, PAX5 , (...)

View the complete list with 51 more genes
Specificity
2 %
Genes
25 %
Comprehensive Hereditary Cancer Panel.

By Blueprint Genetics in Finland.

REST, PPM1D, EXO1, CD70, CEP57, ERCC1, MLH3, DDB2, DIS3L2, NTHL1, HOXB13, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, DDX41, SAMD9L , (...)

View the complete list with 126 more genes
Specificity
1 %
Genes
25 %
Hereditary Paraganglioma-Pheochromocytoma Panel.

By Blueprint Genetics in Finland.

NF1, MAX, SDHD, SDHA, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Central Hypoventilation and Apnea Panel.

By Blueprint Genetics in Finland.

SLC6A5, GLRA1, EDN3, ZEB2, CHRNB1, CHRND, CHRNA1, COLQ, SCN4A, RAPSN, CHRNE, PHOX2B, CHAT, MECP2, RET
Specificity
7 %
Genes
25 %
Comprehensive Pulmonology Panel.

By Blueprint Genetics in Finland.

SLC34A2, PIH1D3, SLC6A5, GLRA1, ITGA3, SFTPA1, SFTPA2, DNAI1, SFTPB, DNAH5, NME8, SFTPC, ABCA3, NKX2-1, DNAH11, DNAI2, DNAAF2, RSPH4A, RSPH9, LTBP4 , (...)

View the complete list with 46 more genes
Specificity
2 %
Genes
25 %
Hereditary Endocrine Cancer Panel.

By Blueprint Genetics in Finland.

DICER1, WRN, AIP, CDKN1B, NF1, CDC73, PRKAR1A, MAX, MET, SDHD, SDHA, MEN1, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, TP53, PTEN , (...)

View the complete list with 2 more genes
Specificity
5 %
Genes
25 %
Hereditary Cancer High Risk Panel.

By Blueprint Genetics in Finland.

POLE, POLD1, BAP1, RAD51D, RAD51C, SMAD4, BMPR1A, CHEK2, CDKN2A, CDK4, STK11, CDH1, PALB2, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1 , (...)

View the complete list with 8 more genes
Specificity
4 %
Genes
25 %
protooncogene RET.

By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" in Argentina.

RET
Specificity
100 %
Genes
25 %
RET Break Apart FISH.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

RET
Specificity
100 %
Genes
25 %
Focus::Oncomine™ NGS Panel.

By Cancer Genetics, Inc. Cancer Genetics, Inc. in United States.

JAK1, ESR1, ROS1, ERBB4, SMO, ERBB2, DDR2, AKT1, GNA11, IDH1, PDGFRA, JAK2, EGFR, GNAQ, PIK3CA, JAK3, KIT, ERBB3, MTOR, CTNNB1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
25 %
Multiple endocrine neoplasia type 2B.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
25 %
Familial medullary thyroid carcinoma.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple endocrine neoplasia type 2A.

By Bioarray in Spain.

RET
Specificity
100 %
Genes
25 %
Solid Tumor Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

BCL2L1, H3F3A, KLF4, TRAF7, PIK3C2B, HIST1H3B, JAK1, MCL1, PBRM1, DAXX, CDKN1A, MYB, MYBL1, RAD54B, ESR2, ESR1, KMT2C, FGFR4, ROS1, NFE2L2 , (...)

View the complete list with 102 more genes
Specificity
1 %
Genes
25 %
Melanoma Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

KMT2C, ROS1, RAC1, ERBB4, ERBB2, CCND1, PDGFRB, AKT1, GNA11, PDGFRA, EGFR, GNAQ, PIK3CA, BAP1, KIT, TERT, MTOR, CTNNB1, MED12, KMT2D , (...)

View the complete list with 18 more genes
Specificity
3 %
Genes
25 %
Breast Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

RAD54B, ESR2, ESR1, RAC1, ERBB4, ERBB2, KDR, CDK6, PIK3R1, AKT1, FBXW7, IDH1, EGFR, PIK3CA, FANCA, KIT, ERBB3, GATA3, FGFR1, BRIP1 , (...)

View the complete list with 22 more genes
Specificity
3 %
Genes
25 %
Thoracic Tumors Gene Set.

By Genomics and Pathology Services Washington University in St. Louis in United States.

KMT2C, ROS1, KEAP1, ERBB2, DDR2, KDR, FLT1, AKT1, AKT3, AKT2, CDKN1B, BAP1, FANCA, FLT4, SMARCA4, ERBB3, MED12, KMT2D, FGFR1, NF1 , (...)

View the complete list with 16 more genes
Specificity
3 %
Genes
25 %
RET Gene Sequencing and Deletion/Duplication Analysis.

By DDC Clinic Molecular Diagnostics Laboratory DDC Clinic, Center for Special Needs Children in United States.

RET
Specificity
100 %
Genes
25 %
Exome.

By DNA CONSULT GENETICA E BIOTECNOLOGIA LTDA. in Brazil.

IPW, SMNDC1, GEMIN2, HERC2, ATXN8, CYP2C9, IL1RN, CCDC88C, VKORC1, CYP2D6, CYP2C19, F8, F9, MAGEL2, SOX9, RPL10, PTCHD1, SEMA3E, SHANK2, KCND3 , (...)

View the complete list with 46 more genes
Specificity
2 %
Genes
25 %
Rapid microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
25 %
High-Resolution Rapid Microarray (CGH and SNP).

By Allele Diagnostics Allele Diagnostics in United States.

CRK, SEM1, IGF2, FBXW4, YWHAE, TBX3, HDAC4, TRPS1, STS, GRIK2, FLI1, PREPL, MAMLD1, ARSE, IRF6, CCNQ, MNX1, NFIA, EDA, XK , (...)

View the complete list with 153 more genes
Specificity
1 %
Genes
25 %
iGene Cancer Panel.

By ApolloGen, Inc. in United States.

NF1, RAD51C, BRIP1, SMAD4, BMPR1A, CDKN2A, STK11, CDH1, PALB2, PTCH1, NBN, ATM, MEN1, RET, TP53, PTEN, MUTYH, MLH1, MSH6, PMS2 , (...)

View the complete list with 5 more genes
Specificity
4 %
Genes
25 %
Multiple Endocrine Neoplasia, Type 2 panel.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

RET
Specificity
100 %
Genes
25 %
Medullary Thyroid Cancer (MTC) Genetic Test.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

RET
Specificity
100 %
Genes
25 %
Genetic Test of single known genetic variant.

By National Taiwan University Hospital A1 Center National Taiwan University Hospital in Taiwan.

GNAS, PKD1, PKD2, TSC1, TSC2, MEN1, RET, TP53, BRCA2, BRCA1
Specificity
10 %
Genes
25 %
FoundationOne® Heme.

By Foundation Medicine, Inc. in United States.

TRAF5, PIM1, PRDM1, HIST1H2AG, HIST1H3B, HIST1H1C, HDAC1, GTSE1, HIST1H1D, HIST1H2BK, HIST1H2BO, HIST1H2BC, HIST1H2AC, HIST1H2AM, HIST1H1E, HIST1H2AL, HDAC7, HIST1H2BJ, INPP5D, IKZF2 , (...)

View the complete list with 385 more genes
Specificity
1 %
Genes
25 %
Guardant360.

By Guardant Health in United States.

MAPK3, RHOA, RHEB, MAPK1, ESR1, NTRK3, ROS1, ARAF, NFE2L2, CCNE1, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, CCND2, AKT1, GNA11, FBXW7 , (...)

View the complete list with 53 more genes
Specificity
2 %
Genes
25 %
Comprehensive Panel for Individualized Cancer Threatment.

By GeneKor MSA in Greece.

ROS1, ERBB4, SMO, ERBB2, DDR2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA , (...)

View the complete list with 32 more genes
Specificity
2 %
Genes
25 %
Hereditary Thyroid Cancer - RET Gene Analysis.

By GeneKor MSA in Greece.

RET
Specificity
100 %
Genes
25 %
Cancer Hotspot Analysis.

By Advanced Technology Laboratory Spectrum Health in United States.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Circulo Thyroid.

By Circulogene Theranostics in United States.

RET
Specificity
100 %
Genes
25 %
Hereditary Cancer Comprehensive Panel.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

TP53BP1, KLLN, CHEK1, GEN1, MYH15, MYH1, MYH13, MYH4, PPM1D, HOXB13, MYH10, GALNT12, RAD51, AKT1, POLE, ABRAXAS1, ETV6, GREM1, POLD1, PIK3CA , (...)

View the complete list with 53 more genes
Specificity
2 %
Genes
25 %
NeoTYPE® Discovery Profile for Solid Tumors.

By NeoGenomics Laboratories NeoGenomics Laboratories, Inc. in United States.

IKBKE, INPP4B, HSP90AA1, LRP1B, BCL2L2, AURKB, LMO1, ARFRP1, MDM4, MAP2K4, MCL1, EMSY, CHEK1, PBRM1, DAXX, PDCD1LG2, EPHB1, EPHA3, DOT1L, EPHA5 , (...)

View the complete list with 295 more genes
Specificity
1 %
Genes
25 %
Caris MI TumorSeek 592-Gene NGS Panel.

By Caris Life Sciences in United States.

ETV1, BCL3, SET, ELL, BTG1, ADGRA2, ACSL3, AFF1, ACSL6, ACKR3, RABEP1, PSIP1, RANBP17, RAD51B, RPL22, SDC4, SH3GL1, REL, SLC45A3, SYK , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
25 %
OmniSeq Comprehensive.

By OmniSeq, Inc. in United States.

NKX2-8, RHOA, BCL2L1, ETV4, ETV1, GAS6, RPS6KB1, RHEB, SPOP, TIAF1, XPO1, ZNF217, JAK1, KNSTRN, IFITM1, APEX1, ATP11B, MDM4, BCL9, BIRC2 , (...)

View the complete list with 124 more genes
Specificity
1 %
Genes
25 %
Otogenetics Hereditary Cancers.

By Otogenetics in United States.

PALLD, RAD51, NF1, NTRK1, RAD51D, BARD1, RAD51C, BRIP1, RAD50, SMAD4, BMPR1A, CHEK2, MET, CDKN2A, CDK4, STK11, CDH1, PALB2, PTCH1, NBN , (...)

View the complete list with 19 more genes
Specificity
3 %
Genes
25 %
HIRSCHSPRUNG´S DISEASE: NGS PANEL.

By Laboratorio de Genetica Clinica SL in Spain.

ECE1, GDNF, SEMA3A, SOX10, EDNRB, EDN3, ZEB2, KIF1BP, RET
Specificity
12 %
Genes
25 %
HYPOVENTILATION SYNDROME, CONGENITAL CENTRAL (ONDINE SYNDROME).

By Laboratorio de Genetica Clinica SL in Spain.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
25 %
PHEOCHROMOCYTOMA-PARAGANGLIOMA.

By Laboratorio de Genetica Clinica SL in Spain.

MAX, SDHD, SDHA, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
25 %
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2 (MEN2).

By Laboratorio de Genetica Clinica SL in Spain.

RET
Specificity
100 %
Genes
25 %
HIRSCHSPRUNG´S DISEASE.

By Laboratorio de Genetica Clinica SL in Spain.

GDNF, SOX10, EDNRB, EDN3, RET
Specificity
20 %
Genes
25 %
THYROID CARCINOMA, MEDULLARY.

By Laboratorio de Genetica Clinica SL in Spain.

RET
Specificity
100 %
Genes
25 %
Solid Tumor Targeted Mutation and Fusion Panel.

By Providence Regional Laboratories Providence Health and Services in United States.

ETV1, JAK1, ERG, ESR1, FGFR4, NTRK3, ROS1, ERBB4, AXL, MYC, SMO, ERBB2, DDR2, CCND1, CDK6, NTRK2, AKT1, AKT3, GNA11, IDH1 , (...)

View the complete list with 30 more genes
Specificity
2 %
Genes
25 %
Renal Agenesis, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Ondine Syndrome, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2A , Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Hirschsprung Disease, Sequencing RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2A, Sequencing Exons (10,11) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2B, Sequencing Exons (15,16) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type FMTC , Sequencing Exons (10,11,13,14) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2, Deletions-Duplications (MLPA) RET Gene.

By Reference Laboratory Genetics in Spain.

RET
Specificity
100 %
Genes
25 %
Oncology Genetic Panel , Panel Massive Sequencing (NGS) 90 Genes.

By Reference Laboratory Genetics in Spain.

CEP57, DDB2, DIS3L2, XPC, RHBDF2, CYLD, BUB1B, XPA, ERCC5, DICER1, WRN, AIP, EXT1, EXT2, EGFR, ERCC4, BAP1, FANCD2, FANCI, FANCL , (...)

View the complete list with 70 more genes
Specificity
2 %
Genes
25 %
Hereditary Pheochromocytoma-Paraganglioma Syndrome , Panel Massive Sequencing (NGS) 11 Genes.

By Reference Laboratory Genetics in Spain.

NF1, MAX, SDHD, SDHA, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, VHL
Specificity
10 %
Genes
25 %
Hirschsprung Disease, Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

ECE1, GDNF, EDNRB, EDN3, L1CAM, RET
Specificity
17 %
Genes
25 %
Ondine Syndrome (Congenital Central Hypoventilation Syndrome), Panel Massive Sequencing (NGS) 6 Genes.

By Reference Laboratory Genetics in Spain.

GDNF, ASCL1, BDNF, EDN3, PHOX2B, RET
Specificity
17 %
Genes
25 %
Hereditary Thyroid Cancer , Panel Massive Sequencing (NGS) 7 Genes.

By Reference Laboratory Genetics in Spain.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
25 %
Cardiology Genetic Panel (Full) , Panel Massive Sequencing (NGS) 96 Genes.

By Reference Laboratory Genetics in Spain.

ECE1, CTNNA3, CACNA1G, GJA5, NPPA, NUP155, SLC6A4, GJA1, DPP6, VCL, MYL3, MYL2, DSC2, CSRP3, ACTN2, RBM20, MYOZ2, JPH2, TNNT2, TPM1 , (...)

View the complete list with 75 more genes
Specificity
2 %
Genes
25 %
Multiple endocrine neoplasia, type 2.

By Labor Dr. Wisplinghoff in Germany.

RET
Specificity
100 %
Genes
25 %
Phosphorus Brain and Nervous System Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, AIP, CDKN1B, SMARCB1, SMARCA4, SMARCE1, NF1, PRKAR1A, MAX, SDHD, SUFU, NF2, PHOX2B, PTCH1, ALK, TSC1, TSC2, HRAS, SDHA, MEN1 , (...)

View the complete list with 15 more genes
Specificity
3 %
Genes
25 %
Phosphorus Thyroid Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DICER1, PRKAR1A, CHEK2, RET, TP53, PTEN, APC
Specificity
15 %
Genes
25 %
Phosphorus Pan-Cancer Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, HOXB13, DICER1, WRN, POT1, AIP, AXIN2, POLE, PDGFRA, EGFR, GREM1, POLD1, CDKN1B, BAP1, XRCC2, KIT, SMARCB1, SMARCA4, SMARCE1, TERT , (...)

View the complete list with 63 more genes
Specificity
2 %
Genes
25 %
Phosphorus Pediatric Cancers Panel.

By Phosphorus Diagnostics LLC in United States.

DIS3L2, DICER1, WRN, AXIN2, BAP1, SMARCB1, TERT, TERC, EZH2, NF1, CDC73, PRKAR1A, CEBPA, GATA2, SMAD4, BMPR1A, MAX, GPC3, SDHD, CDKN1C , (...)

View the complete list with 33 more genes
Specificity
2 %
Genes
25 %
GeneStrat Genomic Test.

By Biodesix, Inc. Biodesix, Inc. in United States.

ROS1, EGFR, ALK, KRAS, BRAF, RET
Specificity
17 %
Genes
25 %
152 Integrated Advantage NGS Solid Tumor Panel.

By Integrated Molecular Diagnostics Pathology, Inc. in United States.

AURKA, TOP1, ABCC1, SLC29A1, STK11IP, SYK, SULT1A1, XRCC1, TOP2A, TOP2B, PLK1, JAK1, JUN, IKBKE, BCL2L2, AURKB, MDM4, MAP2K4, EMSY, CHEK1 , (...)

View the complete list with 132 more genes
Specificity
1 %
Genes
25 %
Tempus xT assay.

By Tempus Labs, Inc. in United States.

HLA-DRB5, HLA-C, PPP6C, ZNRF3, FOXQ1, TBC1D12, WEE1, YEATS4, POU2F2, C8orf34, SEMA3C, PDPK1, HLA-G, LAG3, CCDC6, MEF2B, AURKA, TOP1, P2RY8, FGF4 , (...)

View the complete list with 571 more genes
Specificity
1 %
Genes
25 %
Non syndromic Hirschsprung Disease: gene sequencing panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

SEMA3C, SEMA3D, NRG3, NRG1, NRTN, ECE1, GDNF, EDNRB, EDN3, RET
Specificity
10 %
Genes
25 %
CEN4GEN Comprehensive Hereditary Cancer Syndrome: Gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RAD51B, EHBP1, POU6F2, EPHB2, MSMB, ASCC1, MSR1, XRCC3, PTCH2, PALLD, MLH3, DDB2, DIS3L2, MTAP, POLH, UROD, TMC8, TMC6, PDE11A, XPC , (...)

View the complete list with 123 more genes
Specificity
1 %
Genes
25 %
CEN4GEN Breast cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WEE1, ACVR1B, PTGFR, ZBED4, ZNF226, TRAF5, PPM1L, MAP2K4, PCGF2, PBRM1, FBXO32, EXOC2, NCOR1, MUC16, ESR1, KMT2C, ITCH, MYC, CBFB, ERBB2 , (...)

View the complete list with 25 more genes
Specificity
3 %
Genes
25 %
CEN4GEN Gastric cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

WNK2, ADGRB3, SSTR1, TRRAP, LRP1B, LPAR2, GPR78, ATP4A, CCNE1, TRIO, DCC, MYC, ERBB2, PRKDC, FBXW7, PIK3CA, SPEG, NOTCH1, CTNNB1, S1PR2 , (...)

View the complete list with 9 more genes
Specificity
4 %
Genes
25 %
CEN4GEN Lung cancer: Extended gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ADGRB3, LRP1B, EPHA5, MUC16, GRM8, PIK3CG, ROS1, NFE2L2, KEAP1, ERBB4, MYC, ERBB2, MDM2, RUNX1T1, AKT1, FBXW7, PDGFRA, EGFR, RARB, PIK3CA , (...)

View the complete list with 24 more genes
Specificity
3 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: RET Gene Deletion/Duplication.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RET
Specificity
100 %
Genes
25 %
Endocrine Cancer: gene sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

AIP, CDKN1B, CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
7 %
Genes
25 %
Endocrine Cancer: gene deletion/duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

CDC73, PRKAR1A, MAX, SDHD, MEN1, TMEM127, SDHB, SDHC, RET, SDHAF2, TP53, PTEN, VHL
Specificity
8 %
Genes
25 %
Pheochromocytoma-Paraganglioma: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MAX, SDHD, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
25 %
Pheochromocytoma-Paraganglioma: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

MAX, SDHD, TMEM127, SDHB, FH, SDHC, RET, SDHAF2, VHL
Specificity
12 %
Genes
25 %
CEN4GEN Comprehensive Solid tumors (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ESR1, SMO, ERBB2, AKT1, IDH1, PDGFRA, EGFR, PIK3CA, KIT, MTOR, CTNNB1, MET, CDKN2A, STK11, PTCH1, ATM, MAP2K2, FGFR2, NRAS, KRAS , (...)

View the complete list with 12 more genes
Specificity
4 %
Genes
25 %
CEN4GEN Comprehensive targeted oncogene tumor mutation screen (somatic genetic testing): Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

ERBB4, SMO, ERBB2, KDR, SRC, AKT1, GNA11, FBXW7, IDH1, PDGFRA, ABL1, JAK2, EGFR, NPM1, FLT3, GNAQ, CSF1R, PIK3CA, GNAS, JAK3 , (...)

View the complete list with 28 more genes
Specificity
3 %
Genes
25 %
Multiple Endocrine Neoplasia Type 2: RET Gene Sequencing.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

RET
Specificity
100 %
Genes
25 %
Hereditary Cancer Syndrome: Gene Sequencing Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, AIP, POLD1, CDKN1B, BAP1, XRCC2, MGMT, SMARCB1, SMARCA4, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2 , (...)

View the complete list with 40 more genes
Specificity
2 %
Genes
25 %
Hereditary Cancer Syndrome: Gene Deletion/Duplication Panel.

By CEN4GEN Institute for Genomics and Molecular Diagnostics in Canada.

BUB1B, POLD1, BAP1, XRCC2, SMARCB1, RAD51D, BARD1, RAD51C, CDC73, PRKAR1A, BRIP1, RAD50, SMAD4, BMPR1A, MAX, CHEK2, GPC3, MET, FLCN, SDHD , (...)

View the complete list with 35 more genes
Specificity
2 %
Genes
25 %

Alternate names

Renal Hypodysplasia/aplasia 1; Rhda1 Is also known as renal adysplasia, renal agenesis, renal aplasia, hereditary renal aplasia;hra;.


If you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3; SCAR3